InhaLac^® 300 – a new inhalative lactose grade with specific particle size distribution is characterized by the typical flow- and surface-characteristic of fine milled lactose grades. This provides an additional tool for the formulator to tune and optimize the performance of the DPI product.

InhaLac^® 300 is a lactose grade with 90% of the particles between 35 – 50 μm (Sympatec) or 40 – 56 μm (Malvern).

Inhalation aerosols offers the potential for needle-free systemic delivery of small molecule drugs as well as therapeutic peptides and proteins.  An industry standard in dry power inhalation formulation development, lactose monohydrate is used safely in DPI formulations. Using lactose as an excipient not only improves performance efficiency of the inhaler, but also facilitates powder handling during production. Effective performance of a dry powder inhaler largely depends on the carrier material used for the drug formulation.

With our highly controlled production process different high quality sieved and milled grades are obtained, providing an adequate range of particle sizes – making them behave as individual particles.

Benefits:

• Highly controlled and homogenous powder characteristics
• Highest microbial quality including low endotoxins
• Retest after 24 months

Application:

InhaLac^® 300 is a fine milled lactose suitable for use in pulmonary and nasal drug delivery.

MEGGLE’s extension of the InhaLac^® product family – closing the gap between medium sized carrier lactose and fine milled grades for dry powder inhalation.